US20040224409A1
(en)
*
|
1992-09-25 |
2004-11-11 |
Laurent Pradier |
Recombinant adenoviruses coding for brain-derived neurotrophic factor (BDNF)
|
US5846782A
(en)
|
1995-11-28 |
1998-12-08 |
Genvec, Inc. |
Targeting adenovirus with use of constrained peptide motifs
|
US6465253B1
(en)
|
1994-09-08 |
2002-10-15 |
Genvec, Inc. |
Vectors and methods for gene transfer to cells
|
US6127525A
(en)
*
|
1995-02-21 |
2000-10-03 |
Cornell Research Foundation, Inc. |
Chimeric adenoviral coat protein and methods of using same
|
US5770442A
(en)
*
|
1995-02-21 |
1998-06-23 |
Cornell Research Foundation, Inc. |
Chimeric adenoviral fiber protein and methods of using same
|
US5952226A
(en)
*
|
1996-11-05 |
1999-09-14 |
Modex Therapeutiques |
Hypoxia responsive EPO producing cells
|
US5833651A
(en)
*
|
1996-11-08 |
1998-11-10 |
Medtronic, Inc. |
Therapeutic intraluminal stents
|
US6696423B1
(en)
|
1997-08-29 |
2004-02-24 |
Biogen, Inc. |
Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
|
CA2330172A1
(en)
*
|
1998-06-02 |
1999-12-09 |
University Of Washington |
Prosthetic implant and methods of use for therapeutic gene expression
|
US6537806B1
(en)
|
1998-06-02 |
2003-03-25 |
University Of Washington |
Compositions and methods for treating diabetes
|
US20030017138A1
(en)
|
1998-07-08 |
2003-01-23 |
Menzo Havenga |
Chimeric adenoviruses
|
US6929946B1
(en)
|
1998-11-20 |
2005-08-16 |
Crucell Holland B.V. |
Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
|
US6913922B1
(en)
|
1999-05-18 |
2005-07-05 |
Crucell Holland B.V. |
Serotype of adenovirus and uses thereof
|
US6492169B1
(en)
|
1999-05-18 |
2002-12-10 |
Crucell Holland, B.V. |
Complementing cell lines
|
US7235233B2
(en)
|
2000-09-26 |
2007-06-26 |
Crucell Holland B.V. |
Serotype 5 adenoviral vectors with chimeric fibers for gene delivery in skeletal muscle cells or myoblasts
|
AU2003203527A1
(en)
*
|
2002-04-12 |
2003-10-30 |
Sumitomo Electric Industries, Ltd. |
Control of the ratio of lap to lip
|
BR0308783A
(pt)
|
2002-04-25 |
2005-01-04 |
Crucell Holland Bv |
Vetor de adenovìrus recombinante, método para produzir um vetor de adenovìrus recombinante, composição farmacêutica, método para tratar um corpo humano, e, kit de partes
|
EP1995331A1
(en)
|
2002-05-15 |
2008-11-26 |
Integragen |
Human obesity susceptibility gene and uses thereof
|
AU2004267247B2
(en)
|
2003-08-22 |
2010-02-18 |
Integragen |
Human autism susceptibility gene and uses thereof
|
JP2008504838A
(ja)
|
2004-07-01 |
2008-02-21 |
アンテグラジャン |
Prkcb1をコードするヒト自閉症感受性遺伝子およびその使用
|
DK1863937T3
(da)
|
2005-03-24 |
2010-12-13 |
Integragen Sa |
Humant autisme-susceptibilitetsgen kodende for et transmembranprotein og anvendelser deraf
|
EP1835036A1
(en)
|
2006-03-16 |
2007-09-19 |
Exonhit Therapeutics SA |
Methods and compositions for the detection and treatment of cancers
|
US20100329993A1
(en)
|
2007-06-29 |
2010-12-30 |
Hiroyuki Yoneyama |
Method of fixing and expressing physiologically active substance
|
EP2027868A1
(en)
|
2007-08-24 |
2009-02-25 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Use of SCO-Spondin peptides for inhibiting or preventing neuronal apoptosis mediated by cell death receptor ligands
|
ES2618292T3
(es)
|
2008-01-31 |
2017-06-21 |
Inserm - Institut National De La Sante Et De La Recherche Medicale |
Anticuerpos contra CD39 humano y uso de los mismos para inhibir la actividad de las células T reguladoras
|
EP2355847A1
(en)
|
2008-10-07 |
2011-08-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Neutralizing antibodies and fragments thereof directed against platelet factor-4 variant 1 (pf4v1)
|
EP2199387A1
(en)
|
2008-12-19 |
2010-06-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Serine protease derivatives and uses for the prevention and/or the treatment of blood coagulation disorders
|
CN102325880B
(zh)
|
2008-12-19 |
2014-10-01 |
国家健康与医学研究院 |
丝氨酸蛋白酶衍生物及其在凝血功能障碍的预防或治疗中的用途
|
EP2408818A1
(en)
|
2009-03-17 |
2012-01-25 |
Université de la Méditerranée |
Btla antibodies and uses thereof
|
WO2010128016A2
(en)
|
2009-05-04 |
2010-11-11 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Par2 agonists for use in the treatment or prevention of influenza virus type a infections
|
EP2427497B1
(fr)
|
2009-05-07 |
2016-12-07 |
Stallergenes |
Utilisation d'immunoglobulines igg1 et/ou de ligands du récepteur cd32 pour le traitement de maladies et manifestations inflammatoires par voie mucosale
|
US9050276B2
(en)
|
2009-06-16 |
2015-06-09 |
The Trustees Of Columbia University In The City Of New York |
Autism-associated biomarkers and uses thereof
|
WO2011048443A1
(en)
|
2009-10-20 |
2011-04-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Neuronal exocytosis inhibiting peptides derived from c subunit of v-atpase and cosmetic and pharmaceutical compositions containing said peptides
|
WO2011080322A1
(en)
|
2009-12-30 |
2011-07-07 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Method of prognosing the outcome of acquired hemophilia and of treatment of hemophilia
|
EP2524226A1
(en)
|
2010-01-13 |
2012-11-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Promyelocytic leukemia protein as a redox sensor
|
CA2795390C
(en)
|
2010-04-08 |
2020-11-03 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
|
WO2011147889A1
(en)
|
2010-05-25 |
2011-12-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical composition for the treatment of a feeding disorder with early-onset in a patient
|
US20130150304A1
(en)
|
2010-07-09 |
2013-06-13 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Treatment of a disease associated with retinal degenerative disorder
|
US9040671B2
(en)
|
2010-07-23 |
2015-05-26 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methods for cancer management targeting Co-029
|
US9132173B2
(en)
|
2010-10-15 |
2015-09-15 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Expression vector for cholesterol 24-hydrolase in therapy of Huntington's disease
|
WO2012080769A1
(en)
|
2010-12-15 |
2012-06-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-cd277 antibodies and uses thereof
|
WO2012085132A1
(en)
|
2010-12-22 |
2012-06-28 |
Orega Biotech |
Antibodies against human cd39 and use thereof
|
EP2658869B1
(en)
|
2010-12-30 |
2019-06-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antigen binding formats for use in therapeutic treatments or diagnostic assays
|
WO2012101125A1
(en)
|
2011-01-24 |
2012-08-02 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Specific antibodies against human cxcl4 and uses thereof
|
WO2012120131A1
(en)
|
2011-03-09 |
2012-09-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for generating cell microparticles
|
WO2012120129A1
(en)
|
2011-03-10 |
2012-09-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical composition for the treatment of infectious diseases
|
EA035351B1
(ru)
|
2011-03-31 |
2020-06-01 |
Инсэрм (Инститют Насиональ Де Ля Сантэ Э Де Ля Решерш Медикаль) |
Антитела, направленные против icos, и их применения
|
DK2707391T3
(en)
|
2011-05-13 |
2018-02-05 |
Gamamabs Pharma |
ANTIBODIES AGAINST HER3
|
KR102101806B1
(ko)
|
2011-05-19 |
2020-04-20 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
항-인간-her3 항체 및 이의 용도
|
EP2721057B1
(en)
|
2011-06-15 |
2019-07-31 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Polypeptides isolated from brevibacterium aurantiacum and their use for the treatment of cancer
|
JP6120833B2
(ja)
|
2011-06-22 |
2017-04-26 |
インサーム(インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル)Inserm(Institut National Dela Sante Et De La Recherche Medicale) |
抗Axl抗体及びその使用
|
AU2012273954A1
(en)
|
2011-06-22 |
2014-01-09 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Anti-Axl antibodies and uses thereof
|
EP2543677A1
(en)
|
2011-07-08 |
2013-01-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for the treatment and prevention of thrombosis
|
EP2543678A1
(en)
|
2011-07-08 |
2013-01-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for the treatment and prevention of thrombosis
|
EP2543679A1
(en)
|
2011-07-08 |
2013-01-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for the treatment and prevention of thrombosis
|
FR2979346B1
(fr)
|
2011-08-23 |
2013-09-27 |
Univ Joseph Fourier |
Nanocorps anti-vcam-1
|
WO2013041901A1
(en)
|
2011-09-20 |
2013-03-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for preparing single domain antibody microarrays
|
WO2013139861A1
(en)
|
2012-03-20 |
2013-09-26 |
Luc Montagnier |
Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders
|
WO2013174835A1
(en)
|
2012-05-22 |
2013-11-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for screening a candidate compound for its pharmacology on a nuclear receptor
|
US9605257B2
(en)
|
2012-05-25 |
2017-03-28 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Methods for selecting binders by phage display and masked selection
|
EP2864355B1
(en)
|
2012-06-25 |
2016-10-12 |
Orega Biotech |
Il-17 antagonist antibodies
|
EP2692732A1
(en)
|
2012-08-03 |
2014-02-05 |
Stallergenes S.A. |
Novel allergen from ragweed pollen and uses thereof
|
US9695247B2
(en)
|
2012-09-03 |
2017-07-04 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Antibodies directed against ICOS for treating graft-versus-host disease
|
RS60421B1
(sr)
|
2012-09-07 |
2020-07-31 |
Inserm (Institut National De La Santé Et De La Rech Médicale) |
Inhibitorni peptidi poreklom od aktivirajućeg receptora eksprimiranog na mijeloidnim ćelijama-1 (trem-1) i trem-sličnog transkripta 1 (tlt-1) i njihove upotrebe
|
CN105263956A
(zh)
|
2012-10-12 |
2016-01-20 |
莱斯特大学 |
Csn5多肽及其用于筛选治疗剂的用途
|
EP2733153A1
(en)
|
2012-11-15 |
2014-05-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for the preparation of immunoconjugates and uses thereof
|
KR102408660B1
(ko)
|
2012-11-20 |
2022-06-15 |
사노피 |
항-ceacam5 항체 및 이의 용도
|
EP2749289A1
(en)
|
2012-12-26 |
2014-07-02 |
Institut National De La Recherche Agronomique (INRA) |
Anti-inflammatory peptides
|
US11013783B2
(en)
|
2012-12-26 |
2021-05-25 |
Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement |
Anti-inflammatory peptides and methods for treating inflammatory diseases
|
EP3400961B1
(en)
|
2012-12-27 |
2021-02-24 |
Sanofi |
Anti-lamp1 antibodies and antibody drug conjugates, and uses thereof
|
US9066966B2
(en)
|
2013-02-01 |
2015-06-30 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methods and pharmaceutical compositions for the treatment of cardiomyopathy due to friedreich ataxia
|
ES2698375T3
(es)
|
2013-06-27 |
2019-02-04 |
Inst Nat Sante Rech Med |
Antagonistas de interleucina 15 (IL-15) y usos de los mismos para el tratamiento de enfermedades autoinmunes y enfermedades inflamatorias
|
EP2824176A1
(en)
|
2013-07-11 |
2015-01-14 |
Siamed'xpress |
Methods for producing sialylated therapeutic proteins
|
WO2015067668A1
(en)
|
2013-11-05 |
2015-05-14 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New alzheimer's disease animal model
|
JP6449876B2
(ja)
|
2013-11-07 |
2019-01-09 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
ニューレグリンに対して非競合的でアロステリックな抗ヒトher3抗体及びその使用
|
CA2936954A1
(en)
|
2014-01-20 |
2015-07-23 |
Sanofi |
Novel cytochrome p450 polypeptide with increased enzymatic activity
|
EP3131929B1
(en)
|
2014-04-16 |
2022-06-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for the prevention or the treatment of bleeding episodes
|
FR3020063A1
(fr)
|
2014-04-16 |
2015-10-23 |
Gamamabs Pharma |
Anticorps humain anti-her4
|
EP3131922B1
(en)
|
2014-04-17 |
2020-05-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Polypeptides and uses thereof for reducing cd95-mediated cell motility
|
FR3021970B1
(fr)
|
2014-06-06 |
2018-01-26 |
Universite Sciences Technologies Lille |
Anticorps dirige contre la galectine 9 et inhibiteur de l'activite suppressive des lymphocytes t regulateurs
|
EP2974735A1
(en)
|
2014-07-15 |
2016-01-20 |
Institut National De La Recherche Agronomique (INRA) |
Anti-inflammatory properties of a surface protein of propionibacterium freudenreichii
|
ES2764299T3
(es)
|
2014-12-09 |
2020-06-02 |
Inst Nat Sante Rech Med |
Anticuerpos monoclonales humanos contra AXL
|
LT3247725T
(lt)
|
2015-01-23 |
2020-10-12 |
Sanofi |
Anti-cd3 antikūnai, anti-cd123 antikūnai ir bispecifiniai antikūnai, specifiškai surišantys cd3 ir (arba) cd123
|
WO2016135041A1
(en)
|
2015-02-26 |
2016-09-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Fusion proteins and antibodies comprising thereof for promoting apoptosis
|
EP3273999A1
(en)
|
2015-03-23 |
2018-01-31 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical composition for the treatment and the prevention of neurological phenotype associated with friedreich ataxia
|
EP3091033A1
(en)
|
2015-05-06 |
2016-11-09 |
Gamamabs Pharma |
Anti-human-her3 antibodies and uses thereof
|
US20180125947A1
(en)
|
2015-05-20 |
2018-05-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Treatment of retinal detachment
|
JP6770533B2
(ja)
|
2015-05-22 |
2020-10-14 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
Cath−Dの触媒活性と、そのLRP1レセプターへの結合との両方を阻害するヒトモノクローナル抗体フラグメント
|
EP3319990A1
(en)
|
2015-07-07 |
2018-05-16 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
Antibodies having specificity to myosin 18a and uses thereof
|
WO2017029391A1
(en)
|
2015-08-20 |
2017-02-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method for treating cancer
|
EP3350205A1
(en)
|
2015-09-16 |
2018-07-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Specific interleukin-15 (il-15) antagonist polypeptide and uses thereof for the treatment of inflammatory and auto-immune diseases
|
ES2940360T3
(es)
|
2015-09-22 |
2023-05-05 |
Inst Nat Sante Rech Med |
Polipéptidos capaces de inhibir la unión entre leptina y neuropilina-1
|
WO2017050955A1
(en)
|
2015-09-24 |
2017-03-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Agents capable of inhibiting the binding between leptin and vegf165
|
US11065347B2
(en)
|
2016-01-19 |
2021-07-20 |
The Regents Of The University Of California |
Methods for the treatment of Danon disease and other disorders of autophagy
|
BR112018067525A2
(pt)
|
2016-02-26 |
2019-02-05 |
Centre Nat Rech Scient |
anticorpos tendo especificidade para o btla e seus usos
|
EP3433272A1
(en)
|
2016-03-22 |
2019-01-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Humanized anti-claudin-1 antibodies and uses thereof
|
TWI790206B
(zh)
|
2016-07-18 |
2023-01-21 |
法商賽諾菲公司 |
特異性結合至cd3和cd123的雙特異性抗體樣結合蛋白
|
EP3491022A1
(en)
|
2016-07-29 |
2019-06-05 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
Antibodies targeting tumor associated macrophages and uses thereof
|
CA3036742A1
(en)
|
2016-09-14 |
2018-03-22 |
Universite Catholique De Louvain |
Modified vsv-g and vaccines thereof
|
TWI778985B
(zh)
|
2016-10-20 |
2022-10-01 |
法商賽諾菲公司 |
抗chikv抗體及其用途
|
WO2018077926A1
(en)
|
2016-10-25 |
2018-05-03 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Monoclonal antibodies binding to the cd160 transmembrane isoform
|
FR3058143B1
(fr)
|
2016-10-27 |
2021-03-12 |
Univ Grenoble Alpes |
Nanocorps anti-tau
|
MX2019005235A
(es)
|
2016-11-09 |
2019-12-05 |
Intrexon Corp |
Constructos de expresion de frataxina.
|
WO2018138371A1
(en)
|
2017-01-30 |
2018-08-02 |
Brainvectis |
Expression vector for cholesterol 24-hydrolase in therapy of polyglutamine repeat spinocerebellar ataxias
|
EP3589654A1
(en)
|
2017-03-02 |
2020-01-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies having specificity to nectin-4 and uses thereof
|
KR102584011B1
(ko)
|
2017-03-16 |
2023-09-27 |
이나뜨 파르마 에스.에이. |
암 치료를 위한 조성물 및 방법
|
WO2018178051A1
(en)
|
2017-03-28 |
2018-10-04 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Scgb1a1 polymorphism for the prediction and therapy or prevention of primary graft dysfunction
|
EP3388072A1
(en)
|
2017-04-10 |
2018-10-17 |
Universität Leipzig |
Ubiquinone-independent cytoplasmic dihydroorotate dehydrogenase for use as medicament
|
CA3066047A1
(en)
|
2017-06-14 |
2018-12-20 |
Technische Universitat Dresden |
Methods and means for genetic alteration of genomes utilizing designer dna recombining enzymes
|
EP3658581A1
(en)
|
2017-07-24 |
2020-06-03 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies and peptides to treat hcmv related diseases
|
WO2019038420A1
(en)
|
2017-08-25 |
2019-02-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OSTEOCLAST DISEASES
|
CA3074933A1
(en)
|
2017-09-21 |
2019-03-28 |
Imcheck Therapeutics Sas |
Antibodies having specificity for btn2 and uses thereof
|
MX2020012107A
(es)
|
2018-06-18 |
2021-01-29 |
Innate Pharma |
Composiciones y procedimientos para el tratamiento del cancer.
|
ES2936254T3
(es)
|
2018-10-29 |
2023-03-15 |
Inst Nat Sante Rech Med |
Vector de expresión para la colesterol 24-hidrolasa en la terapia de la esclerosis lateral amiotrófica
|
WO2020148207A1
(en)
|
2019-01-14 |
2020-07-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Human monoclonal antibodies binding to hla-a2
|
CN113508129A
(zh)
|
2019-01-15 |
2021-10-15 |
法国国家健康和医学研究院 |
突变的白介素-34(il-34)多肽及其在治疗中的用途
|
SG11202109932WA
(en)
|
2019-03-20 |
2021-10-28 |
Imcheck Therapeutics Sas |
Antibodies having specificity for btn2 and uses thereof
|
WO2020193441A1
(en)
|
2019-03-22 |
2020-10-01 |
Université de Paris |
New inhibitors of lrrk2/pp1 interaction
|
US20220177558A1
(en)
|
2019-03-25 |
2022-06-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Treatment of taupathy disorders by targeting new tau species
|
EP3972997A1
(en)
|
2019-05-20 |
2022-03-30 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Novel anti-cd25 antibodies
|
EP3972631B1
(en)
|
2019-05-21 |
2024-07-10 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Expression vector for cholesterol 24-hydrolase in therapy of rett syndrome
|
CN114206938A
(zh)
|
2019-06-20 |
2022-03-18 |
国家医疗保健研究所 |
抗蛋白酶nexin-1构象单域抗体及其用途
|
US20220251567A1
(en)
|
2019-07-10 |
2022-08-11 |
Inserm (Institut National De La Santè Et De La Recherche Médicale) |
Methods for the treatment of epilepsy
|
CN114258401A
(zh)
|
2019-07-16 |
2022-03-29 |
Inserm(法国国家健康医学研究院) |
对cd38具有特异性的抗体及其用途
|
WO2021009299A1
(en)
|
2019-07-17 |
2021-01-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Bcl-xl:fkbp12 fusion proteins suitable for screening agents capable of slowing down the aging process
|
US20210032370A1
(en)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Recruiting agent further binding an mhc molecule
|
JP2022543259A
(ja)
|
2019-08-02 |
2022-10-11 |
オレガ・バイオテック |
新規il-17b抗体
|
DE102019121007A1
(de)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Antigenbindende Proteine, die spezifisch an MAGE-A binden
|
EP4025206A1
(en)
|
2019-09-02 |
2022-07-13 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Methods and compositions for treating pax6- deficiency related disease
|
CN114341183B
(zh)
|
2019-09-04 |
2024-04-16 |
Inserm(法国国家健康医学研究院) |
Il20-rb特异性抗体及其用于治疗慢性阻塞性肺疾病急性恶化的用途
|
WO2021048171A1
(en)
|
2019-09-10 |
2021-03-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method to improve phagocytosis
|
WO2021058684A1
(en)
|
2019-09-24 |
2021-04-01 |
Université Catholique de Louvain |
Modified vesicular stomatitis virus glycoprotein and uses thereof for the treatment of brain tumors
|
WO2021058729A1
(en)
|
2019-09-27 |
2021-04-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-müllerian inhibiting substance type i receptor antibodies and uses thereof
|
JP2022550325A
(ja)
|
2019-09-27 |
2022-12-01 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
抗ミュラー管抑制物質抗体およびその使用
|
EP3812008A1
(en)
|
2019-10-23 |
2021-04-28 |
Gamamabs Pharma |
Amh-competitive antagonist antibody
|
EP4061943A1
(en)
|
2019-11-19 |
2022-09-28 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Antisense oligonucleotides and their use for the treatment of cancer
|
WO2021099576A1
(en)
|
2019-11-21 |
2021-05-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Novel immunotherapies targeting pd-1 with anti-pd-1/il-15 immunocytokines
|
EP4072682A1
(en)
|
2019-12-09 |
2022-10-19 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Antibodies having specificity to her4 and uses thereof
|
US20230132241A1
(en)
|
2020-01-15 |
2023-04-27 |
Immatics Biotechnologies Gmbh |
Antigen binding proteins specifically binding prame
|
EP4096707A1
(en)
|
2020-01-30 |
2022-12-07 |
Umoja Biopharma, Inc. |
Bispecific transduction enhancer
|
WO2021175954A1
(en)
|
2020-03-04 |
2021-09-10 |
Imcheck Therapeutics Sas |
Antibodies having specificity for btnl8 and uses thereof
|
KR20230008751A
(ko)
|
2020-05-12 |
2023-01-16 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
피부 t-세포 림프종 및 tfh 유래된 림프종을 치료하는 신규한 방법
|
US20230265211A1
(en)
|
2020-06-29 |
2023-08-24 |
Inserm (Institut National De La Santé Et De Ls Recherche Médicale) |
Anti-protein s single-domain antibodies and polypeptides comprising thereof
|
CA3185267A1
(en)
|
2020-08-07 |
2022-02-10 |
Spacecraft Seven, Llc |
Plakophilin-2 (pkp2) gene therapy using aav vector
|
CA3190586A1
(en)
|
2020-09-04 |
2022-03-10 |
Merck Patent Gmbh |
Anti-ceacam5 antibodies and conjugates and uses thereof
|
MX2023005570A
(es)
|
2020-11-12 |
2023-05-29 |
Inst Nat Sante Rech Med |
Anticuerpos conjugados o fusionados al dominio de union del receptor de la proteina de la espicula de sars-cov-2 y usos de los mismos con fines de vacunacion.
|
MX2023007610A
(es)
|
2020-12-23 |
2023-07-12 |
Inst Nat Sante Rech Med |
Vacuna contra clamidia basada en el direccionamiento del antigeno momp vs4 a las celulas presentadoras de antigeno.
|
WO2022152698A1
(en)
|
2021-01-12 |
2022-07-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of npdk-d to evaluate cancer prognosis
|
EP4281187A1
(en)
|
2021-01-20 |
2023-11-29 |
Bioentre LLC |
Ctla4-binding proteins and methods of treating cancer
|
WO2022164935A1
(en)
|
2021-01-27 |
2022-08-04 |
Umoja Biopharma, Inc. |
Lentivirus for generating cells expressing anti-cd19 chimeric antigen receptor
|
KR20230135620A
(ko)
|
2021-01-29 |
2023-09-25 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
클라미디아 트라코마티스 항원 폴리펩타이드 및 백신목적을 위한 이의 용도
|
WO2022184805A1
(en)
|
2021-03-03 |
2022-09-09 |
Immatics Biotechnologies Gmbh |
Antigen binding proteins specifically binding sars-cov-2 antigenic peptides in complex with a major histocompatibility complex protein
|
WO2022200469A1
(en)
|
2021-03-24 |
2022-09-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
A dominant negative protein of rad51 for treating cancer
|
US20240228659A1
(en)
|
2021-04-14 |
2024-07-11 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method to improve nk cells cytotoxicity
|
EP4322937A1
(en)
|
2021-04-14 |
2024-02-21 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
New method to improve the anti-tumoral activity of macrophages
|
IL308257A
(en)
|
2021-05-05 |
2024-01-01 |
Immatics Biotechnologies Gmbh |
Antigen binding proteins that uniquely bind PRAME
|
WO2022238974A1
(en)
|
2021-05-13 |
2022-11-17 |
Universidade Do Algarve |
Isolated or artificial nucleotide sequences for use in neurodegenerative diseases
|
EP4377330A1
(en)
|
2021-07-27 |
2024-06-05 |
Immatics Biotechnologies GmbH |
Antigen binding proteins specifically binding ct45
|
EP4381069A1
(en)
|
2021-08-02 |
2024-06-12 |
Universite De Montpellier |
Compositions and methods for treating cmt1a or cmt1e diseases with rnai molecules targeting pmp22
|
EP4130038A1
(en)
|
2021-08-03 |
2023-02-08 |
Institut national de recherche pour l'agriculture, l'alimentation et l'environnement |
Anti-il-2 antibody, complex comprising it, and uses thereof
|
AU2022386716A1
(en)
|
2021-11-15 |
2024-05-02 |
Technische Universität Dresden |
Site-specific recombinases for efficient and specific genome editing
|
KR20240103030A
(ko)
|
2021-11-17 |
2024-07-03 |
인스티튜트 내셔날 드 라 싼테 에 드 라 리셰르셰 메디칼르 |
범용 사르베코바이러스 백신
|
WO2023099578A1
(en)
|
2021-12-01 |
2023-06-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Neutralizing anti-cd95l monoclonal antibodies
|
EP4209508A1
(en)
|
2022-01-11 |
2023-07-12 |
Centre national de la recherche scientifique |
Nanobodies for the deneddylating enzyme nedp1
|
WO2023150563A1
(en)
|
2022-02-01 |
2023-08-10 |
Cornell University |
Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy associated with friedreich ataxia
|
WO2023156437A1
(en)
|
2022-02-16 |
2023-08-24 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-robo4 human monoclonal antibodies and uses thereof for the treatment of cancer
|
WO2023161412A1
(en)
|
2022-02-25 |
2023-08-31 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies for preventing the cleavage of cd95l by metalloproteases
|
WO2023170239A1
(en)
|
2022-03-09 |
2023-09-14 |
Merck Patent Gmbh |
Methods and tools for conjugation to antibodies
|
WO2023170296A1
(en)
|
2022-03-11 |
2023-09-14 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Nucleic acid system to specifically reprogram b and t cells and uses thereof
|
WO2023217904A1
(en)
|
2022-05-10 |
2023-11-16 |
Institut National de la Santé et de la Recherche Médicale |
Syncitin-1 fusion proteins and uses thereof for cargo delivery into target cells
|
WO2023240287A1
(en)
|
2022-06-10 |
2023-12-14 |
Bioentre Llc |
Combinations of ctla4 binding proteins and methods of treating cancer
|
WO2024011237A1
(en)
|
2022-07-08 |
2024-01-11 |
Cornell University |
Methods and pharmaceutical compositions for the treatment and the prevention of alzheimers disease
|
WO2024017990A1
(en)
|
2022-07-21 |
2024-01-25 |
Institut National de la Santé et de la Recherche Médicale |
Methods and compositions for treating chronic pain disorders
|
WO2024052503A1
(en)
|
2022-09-08 |
2024-03-14 |
Institut National de la Santé et de la Recherche Médicale |
Antibodies having specificity to ltbp2 and uses thereof
|
WO2024056668A1
(en)
|
2022-09-12 |
2024-03-21 |
Institut National de la Santé et de la Recherche Médicale |
New anti-itgb8 antibodies and its uses thereof
|
WO2024061930A1
(en)
|
2022-09-22 |
2024-03-28 |
Institut National de la Santé et de la Recherche Médicale |
New method to treat and diagnose peripheral t-cell lymphoma (ptcl)
|
WO2024074571A1
(en)
|
2022-10-05 |
2024-04-11 |
Institut National de la Santé et de la Recherche Médicale |
Dc-targeting vaccine against nipah virus infection
|
WO2024079317A1
(en)
|
2022-10-14 |
2024-04-18 |
Institut National de la Santé et de la Recherche Médicale |
Methods and pharmaceutical composition for the treatment of alpha-synucleinopathies
|
PT118269A
(pt)
|
2022-10-20 |
2024-04-22 |
Univ Aveiro |
Pkmyt1 for use in regenerative medicine
|
WO2024098028A2
(en)
|
2022-11-04 |
2024-05-10 |
Umoja Biopharma, Inc. |
Lentiviral particles displaying fusion molecules and uses thereof
|
WO2024097992A2
(en)
|
2022-11-04 |
2024-05-10 |
Umoja Biopharma, Inc. |
Particles displaying adhesion-molecule fusions
|
WO2024146935A1
(en)
|
2023-01-06 |
2024-07-11 |
Institut National de la Santé et de la Recherche Médicale |
Intravenous administration of antisense oligonucleotides for the treatment of pain
|